title: Recommendations for the clinical use of cyclooxygenase-2-specific inhibitors.
authors.affiliation: Rheumatic Diseases Division, The University of Texas Southwestern Medical Center at Dallas, Dallas, Texas, USA.
authors.forename: P E
authors.initials: PE
authors.lastname: Lipsky
mesh_terms: D000465:Algorithms; D000894:Anti-Inflammatory Agents, Non-Steroidal / Q000627:therapeutic use*; D051546:Cyclooxygenase 2; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors / Q000627:therapeutic use*; D003663:Decision Trees; D005767:Gastrointestinal Diseases / Q000139:chemically induced / Q000517:prevention & control; D006801:Humans; D007527:Isoenzymes / Q000037:antagonists & inhibitors*; D008565:Membrane Proteins; D018579:Patient Selection; D017410:Practice Guidelines as Topic; D011451:Prostaglandin-Endoperoxide Synthases; D012307:Risk Factors
chemical_list: D000894:Anti-Inflammatory Agents, Non-Steroidal; D052246:Cyclooxygenase 2 Inhibitors; D016861:Cyclooxygenase Inhibitors; D007527:Isoenzymes; D008565:Membrane Proteins; D051546:Cyclooxygenase 2; C496540:PTGS2 protein, human; D011451:Prostaglandin-Endoperoxide Synthases